These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 35959996)

  • 21. Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD
    Koczor CA; Saville KM; Andrews JF; Clark J; Fang Q; Li J; Al-Rahahleh RQ; Ibrahim M; McClellan S; Makarov MV; Migaud ME; Sobol RW
    Cell Rep; 2021 Nov; 37(5):109917. PubMed ID: 34731617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
    Kim IK; Stegeman RA; Brosey CA; Ellenberger T
    J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitotic functions of poly(ADP-ribose) polymerases.
    Slade D
    Biochem Pharmacol; 2019 Sep; 167():33-43. PubMed ID: 30910692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal recruitment of base excision DNA repair factors in living cells in response to different micro-irradiation DNA damage protocols.
    Zhao ML; Stefanick DF; Nadalutti CA; Beard WA; Wilson SH; Horton JK
    DNA Repair (Amst); 2023 Jun; 126():103486. PubMed ID: 37028218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response.
    Yue W; Li X; Zhan X; Wang L; Ma J; Bi M; Wang Q; Gu X; Xie B; Liu T; Guo H; Zhu X; Song C; Qiao J; Li M
    EBioMedicine; 2024 May; 103():105129. PubMed ID: 38640836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Role of the WGR Domain in the Functions of PARP1 and PARP2].
    Maluchenko NV; Korovina AN; Saulina AA; Studitsky VM; Feofanov AV
    Mol Biol (Mosk); 2023; 57(5):782-791. PubMed ID: 37752643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single molecule detection of PARP1 and PARP2 interaction with DNA strand breaks and their poly(ADP-ribosyl)ation using high-resolution AFM imaging.
    Sukhanova MV; Abrakhi S; Joshi V; Pastre D; Kutuzov MM; Anarbaev RO; Curmi PA; Hamon L; Lavrik OI
    Nucleic Acids Res; 2016 Apr; 44(6):e60. PubMed ID: 26673720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avoid the trap: Targeting PARP1 beyond human malignancy.
    Kim C; Chen C; Yu Y
    Cell Chem Biol; 2021 Apr; 28(4):456-462. PubMed ID: 33657415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
    Hopkins TA; Shi Y; Rodriguez LE; Solomon LR; Donawho CK; DiGiammarino EL; Panchal SC; Wilsbacher JL; Gao W; Olson AM; Stolarik DF; Osterling DJ; Johnson EF; Maag D
    Mol Cancer Res; 2015 Nov; 13(11):1465-77. PubMed ID: 26217019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells.
    Kanev PB; Varhoshkova S; Georgieva I; Lukarska M; Kirova D; Danovski G; Stoynov S; Aleksandrov R
    Cell Rep; 2024 May; 43(5):114234. PubMed ID: 38758646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair.
    Demin AA; Hirota K; Tsuda M; Adamowicz M; Hailstone R; Brazina J; Gittens W; Kalasova I; Shao Z; Zha S; Sasanuma H; Hanzlikova H; Takeda S; Caldecott KW
    Mol Cell; 2021 Jul; 81(14):3018-3030.e5. PubMed ID: 34102106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Roles of PARP2 in Assembling Protein-Protein Complexes Involved in Base Excision DNA Repair.
    Vasil'eva I; Moor N; Anarbaev R; Kutuzov M; Lavrik O
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-
    Johannes JW; Balazs A; Barratt D; Bista M; Chuba MD; Cosulich S; Critchlow SE; Degorce SL; Di Fruscia P; Edmondson SD; Embrey K; Fawell S; Ghosh A; Gill SJ; Gunnarsson A; Hande SM; Heightman TD; Hemsley P; Illuzzi G; Lane J; Larner C; Leo E; Liu L; Madin A; Martin S; McWilliams L; O'Connor MJ; Orme JP; Pachl F; Packer MJ; Pei X; Pike A; Schimpl M; She H; Staniszewska AD; Talbot V; Underwood E; Varnes JG; Xue L; Yao T; Zhang K; Zhang AX; Zheng X
    J Med Chem; 2021 Oct; 64(19):14498-14512. PubMed ID: 34570508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
    Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M
    Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin.
    Hanzlikova H; Gittens W; Krejcikova K; Zeng Z; Caldecott KW
    Nucleic Acids Res; 2017 Mar; 45(5):2546-2557. PubMed ID: 27965414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin.
    Bilokapic S; Suskiewicz MJ; Ahel I; Halic M
    Nature; 2020 Sep; 585(7826):609-613. PubMed ID: 32939087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PARP trapping is governed by the PARP inhibitor dissociation rate constant.
    Gopal AA; Fernandez B; Delano J; Weissleder R; Dubach JM
    Cell Chem Biol; 2024 Jul; 31(7):1373-1382.e10. PubMed ID: 38262416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib.
    Ding X; Zhu Z; Lapek J; McMillan EA; Zhang A; Chung CY; Dubbury S; Lapira J; Firdaus S; Kang X; Gao J; Oyer J; Chionis J; Rollins RA; Li L; Niessen S; Bagrodia S; Zhang L; VanArsdale T
    Sci Rep; 2022 Jul; 12(1):12501. PubMed ID: 35864202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.